Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Britannia Life Sciences's Average Total Inventories for the quarter that ended in Mar. 2026 was $0.00 Mil. Britannia Life Sciences's Revenue for the
three
months ended in Mar. 2026 was $-0.21 Mil.
Britannia Life Sciences's Inventory-to-Revenue for the quarter that ended in Mar. 2026
stayed the same
from Dec. 2025 (0.00) to Dec. 2025 (0.00)
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Britannia Life Sciences's Days Inventory for the
three
months ended in Mar. 2026 was 0.00.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Britannia Life Sciences (OTCPK:BLSIF) Inventory-to-Revenue Explanation
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
More Related Terms:
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Britannia Life Sciences's Days Inventory for the
three
months ended in Mar. 2026 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Britannia Life Sciences Inventory-to-Revenue Related Terms
Britannia Life Sciences Inventory-to-Revenue Historical Data
* Premium members only.
The historical data trend for Britannia Life Sciences's Inventory-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Britannia Life Sciences Inventory-to-Revenue Chart
BLSIF vs VRTX, REGN, MRNA: Inventory-to-Revenue Comparison
For the Biotechnology subindustry, Britannia Life Sciences's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Britannia Life Sciences Inventory-to-Revenue vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Britannia Life Sciences's Inventory-to-Revenue distribution charts can be found below:
* The bar in red indicates where Britannia Life Sciences's Inventory-to-Revenue falls into.
Britannia Life Sciences Inventory-to-Revenue Calculation
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Britannia Life Sciences's Inventory-to-Revenue for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Britannia Life Sciences (BLSIF) has a Inventory-to-Revenue of 0.00 as of Mar. 2026. Inventory-to-Sales ratio is the total inventories divided by total sales. View historical data on Britannia Life Sciences and its competitors.
Is Britannia Life Sciences' Inventory-to-Revenue too high?
Britannia Life Sciences' current Inventory-to-Revenue is 0.00.
How does Britannia Life Sciences' Inventory-to-Revenue compare to VRTX and REGN?
Britannia Life Sciences' Inventory-to-Revenue of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventory-to-Revenue for a Biotechnology company?
A good Inventory-to-Revenue depends on the Biotechnology industry context. However, Inventory-to-Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventory-to-Revenue mean?
A high Inventory-to-Revenue can signal that a stock is expensive relative to its fundamentals. Inventory-to-Sales ratio is the total inventories divided by total sales. View historical data on Britannia Life Sciences and its competitors. Britannia Life Sciences's current Inventory-to-Revenue is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Britannia Life Sciences stock overvalued right now?
Britannia Life Sciences (BLSIF) has a current Inventory-to-Revenue of 0.00. The current Inventory-to-Revenue is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventory-to-Revenue calculated?
Inventory-to-Revenue is calculated from a company's financial statements. For Britannia Life Sciences (BLSIF), the current Inventory-to-Revenue is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Britannia Life Sciences Inc provides product testing, safety assessment, and manufacturing services to the cosmetic and consumer packaged goods industries in the United Kingdom and globally.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BLSIF has been successfully added to your 
